| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |